Royal Bank of Canada
IGC icon

Royal Bank of Canada’s IGC Pharma IGC Stock Holding History

Royal Bank of Canada’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-290
Closed – – 7541
2020
Q4 		$0 Hold
290
– – ﹤0.01% 7164
2020
Q3 		$0 Buy
290
+36
+14% +$37 ﹤0.01% 6759
2020
Q2 		$0 Buy
254
+132
+108% +$72 ﹤0.01% 6740
2020
Q1 		$0 Buy
+122
New +$68 ﹤0.01% 6822
2018
Q4 		– Sell
-1,670
Closed -$11K – 6909
2018
Q3 		$11K Hold
1,670
– – ﹤0.01% 5943
2018
Q2 		$1K Hold
1,670
– – ﹤0.01% 6358
2018
Q1 		$1K Hold
1,670
– – ﹤0.01% 6205
2017
Q4 		$2K Buy
+1,670
New +$923 ﹤0.01% 6277

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $29.1B AUM 22.79% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Royal Bank of Canada's IGC Position: Q1 2021 in Review

Royal Bank of Canada sold out of IGC Pharma (IGC) in Q1 2021, closing a stake of 290 shares.

Royal Bank of Canada first reported a position in IGC in Q4 2017 and held it in 8 quarters. The position peaked at $11K in Q3 2018. 29 funds tracked by Wall St. Rank hold IGC as of Q1 2021.

  • Royal Bank of Canada reported no remaining IGC Pharma position as of Q1 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 290 IGC Pharma shares in Q1 2021.
  • Royal Bank of Canada first reported a position in IGC Pharma in Q4 2017 and held it in 8 quarters.
  • Royal Bank of Canada's IGC Pharma position peaked at $11K in Q3 2018.
  • 29 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2021.

Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.